MedTrace Logo

Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension

NCT03388476 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-05-19

No results posted yet for this study

Summary

Measurement of the endtidal carbon dioxide by capnography to exclude or to ensure the diagnosis pulmonary hypertension. The aim of the study is to obtain an endtidal carbon dioxide cut-off value for the diagnostic algorithm for pulmonary hypertension as an easily measurable and cheap diagnostic tool in patients with suspicion of pulmonary hypertension.

Conditions

  • Hypertension, Pulmonary
  • Hypertension;Pulmonary;Primary
  • Chronic Thromboembolic Pulmonary Hypertension
  • Vascular Diseases
  • Lung Diseases

Interventions

DIAGNOSTIC_TEST

Capnography

Measuring of the exhaled air, especially endtidal co2, through capnography.

Sponsors & Collaborators

  • University of Giessen

    lead OTHER

Principal Investigators

  • Henning Gall, MD, PhD · University Clinic Giessen and Marburg - Campus Giessen

  • Werner Seeger, Prof. · University Clinic Giessen and Marburg

  • Ardeschir Ghofrani, Prof. · University Clinic Giessen and Marburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-02
Primary Completion
2030-01-01
Completion
2035-01-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03388476 on ClinicalTrials.gov